Prevention of aromatase inhibitor-induced bone loss using risedronate: the SABRE trial

2022-08-18T19:00:30+02:00Research and Publications|

Van Poznak C, Hannon RA, Mackey JR, Campone M, Apffelstaedt JP, Clack G, Barlow D, Makris A, Eastell R. J Clin Oncol. 2010 Feb 20;28(6):967-75. Epub 2010 Jan 11. PMID: 20065185 [PubMed - indexed for MEDLINE] http://www.ncbi.nlm.nih.gov/pubmed/20065185